作者: Scott M. Lippman , Bonnie S. Glisson , John J. Kavanagh , Reuben Lotan , Waun Ki Hong
DOI: 10.1016/0959-8049(93)90618-P
关键词:
摘要: Retinoic acid and interferon-alpha have limited single-agent activity in advanced cancer. Cell culture data indicate that combination these agents enhanced (modulating growth differentiation) a number of malignant cell types. Recent clinical work squamous carcinoma reports major with this regimen. This paper reviews the preclinical testing retinoic interferons presents recent integrating radiotherapy locally cervical